Clinical Trials Browser

Phase 3 × Basal Cell Nevus Syndrome × Clear all

NCT06050122 2025-10-14

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

Phase 3 Active not recruiting

Basal Cell Nevus Syndrome

NCT04308395 2024-09-24

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Phase 3 Terminated

108 enrolled 12 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT03703310 2024-07-03

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Phase 3 Completed

174 enrolled 23 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00049959 2011-03-16

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

Phase 3 Terminated

Basal cell carcinoma, multiple, Basal Cell Nevus Syndrome, Carcinoma, Basal Cell